Literature DB >> 20231994

Enterococcal urinary tract infections in a university hospital: clinical studies.

Milton Barros1, Reinaldo Martinelli, Heonir Rocha.   

Abstract

Although urinary tract infections (UTI) represent the most common infection caused by enterococci, some aspects remain to be fully clarified. The aim of this study was to determine the clinical characteristics present in UTI caused by Enterococcus spp. in patients followed up at the Prof. Edgard Santos Teaching Hospital of the Federal University of Bahia. All patients consecutively examined between 1997 and 2005, who received a diagnosis of UTI caused by Enterococcus spp. were included in the study. UTI was defined as the presence of > or = 10(5) colony-forming units per mL of urine. Standard microbiological techniques were used. During the study period, 6.2% of the urine cultures were positive for Enterococcus spp. The mean age of the patients was 48.9 years and 57% were male. At initial evaluation, 13% of the patients had complaints suggestive of UTI. Nineteen patients had a history consistent with obstructive uropathy and 26 with neurogenic bladder. At final evaluation, UTI was the diagnosis in 48 patients. In 36 patients (29%), the primary diagnosis was related to urogenital diseases, consisting of obstructive uropathy in 23 of these cases, while in 32 patients (25.8%) primary diagnosis was related to neurologic diseases, frequently neurogenic bladder. UTI caused by Enterococcus spp. is not infrequent, is usually associated with few or no symptoms and occurs in sick patients who have anatomical or functional obstructive uropathy associated or not with urinary tract catheterization or instrumentation. The diagnosis of enterococcal UTI may indicate a urinary tract abnormality yet to be diagnosed.

Entities:  

Mesh:

Year:  2009        PMID: 20231994     DOI: 10.1590/s1413-86702009000400011

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

1.  Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.

Authors:  H N Khair; P VanTassell; J P Henderson; D K Warren; J Marschall
Journal:  J Hosp Infect       Date:  2013-08-30       Impact factor: 3.926

2.  High level aminoglycoside resistant enterococci in hospital-acquired urinary tract infections in Mansoura, Egypt.

Authors:  Rasha El-Mahdy; Ahmed Mostafa; Ghada El-Kannishy
Journal:  Germs       Date:  2018-12-03

3.  Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital.

Authors:  Amelework Yilema; Feleke Moges; Sisay Tadele; Mengistu Endris; Afework Kassu; Wondwossen Abebe; Getnet Ayalew
Journal:  BMC Infect Dis       Date:  2017-04-17       Impact factor: 3.090

4.  Emerging resistance of van genotype in enterococci: A potential menace for therapeutic failure.

Authors:  Hasan Ejaz
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

5.  Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends.

Authors:  Márió Gajdács; Marianna Ábrók; Andrea Lázár; Katalin Burián
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

6.  A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The "Triple F" approach supported by Procalcitonin and paired blood and urine cultures.

Authors:  Kathrin Rothe; Christoph D Spinner; Birgit Waschulzik; Christian Janke; Jochen Schneider; Heike Schneider; Krischan Braitsch; Christopher Smith; Roland M Schmid; Dirk H Busch; Juri Katchanov
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

7.  Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in Bulgaria.

Authors:  Tanya Strateva; Daniela Atanasova; Encho Savov; Guergana Petrova; Ivan Mitov
Journal:  Braz J Infect Dis       Date:  2016-02-02       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.